StockWireNews

Today's New Biotech Profile (Inside) Requires Immediate Attention - Must Read Full Report

Based On This Report, See Why PHBI Could Be Significantly Undervalued While Displaying Staggering Upside Potential

April 30th

Good Morning,

Before today's opening bell, I want you to focus in on what I consider my #1 stock idea in the Biotech and Green Wave sectors:

Your new breakout profile is:

Pharmagreen Biotech Inc. (PHBI)

Pharmagreen is a biotech sciences company with specialized products and services.

Yahoo Finance reports PHBI to currently have 16.1Mn shares in its float meaning volatility could lead to price spiking if above average momentum floods into this profile.

Here's why this could happen...

The Top #1 PHBI Catalyst - New Ground-Breaking Complex

Pharmagreen Selects ICF (Insulated Concrete Forms) Building Technology for the Construction of its [...] Biotech Complex Building Material

CARSON CITY, NV, Jan. 16, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Pharmagreen Biotech, Inc., (OTC: PHBI), is pleased to announce today that it signed a memorandum of understanding with Here to Serve Holding Corp., (OTC:HTSC) to provide consulting services and supply ICF building material (Insulated Concrete Forms) for the construction of Pharmagreen’s 63,000 square foot facility, the [...] Biotech Complex.

The complex, which will take about 18 months to construct, makes use of cutting edge technologies in its engineering, water recycling and conservation techniques, as well as with its construction material resulting in a reduced carbon footprint and secure, uniquely advanced, eco-friendly and semi-automated tissue culture, clean-room laboratory, extraction, distillation and research facility.

Read the full article here.

The biotech complex is projected to provide the annual in-vitro production and supply of over 10 million "Green Wave" tissue cultured plantlets and ready-to-grow starter crops for:

1. Licensed commercial grow operations
2. Micro-cultivators
3. Orchard style high CB hemp farms

According to Cesar Herrera, President of Here To Serve Holding Corp, "We believe Pharmagreen's biotech tissue culture complex will be the world's first truly state-of-the-art "Green Wave" facility.

Peter Wojcik, President and CEO of Pharmagreen stated, “We are building our complex to the highest standards in engineering and building materials..."

With PHBI trading in the $.50 range, it could just be a matter of time until traders pay attention to how game-changing this new complex could be for the company.

If that happens, share prices could spike massively in the short-term. $.08 per share may end up looking extremely undervalued.

Here are even more reasons to pay attention to PHBI...

PHBI's Next 3 Catalysts Driving Potential Share Price Growth

Catalyst #1: Pharmagreen Provides Update

CARSON CITY, NV, Dec. 12, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Pharmagreen Biotech, Inc., (OTC PINKS: PHBI), is pleased to provide a company development update. The company has secured significant credit facility to date and plans to use the funds to move forward with its projects development to build a state of the art all year round greenhouse and a tissue cultured starter plantlet production facility. The all year round greenhouse was added to the company’s plans for a first build out as time to complete construction is less than six months and revenue producing within 3 months of operations. The greenhouse will allow the company to earn revenues while the tissue culture facility is under construction.

Here are your 3 main takeaways from this PR snip-it:

No. 1 - PHBI has secured a significant line of credit to push forward its company's growth.

No. 2 - They are moving forward with development on their 24/7/365 production facility.

No. 3 - After completing construction in less than 6 months, it will only take PHBI 3 additional months to start churning out revenues.

Catalyst #2: Pharmagreen Biotech is Seeking to Revolutionize Cancer Research and More with Their Botany Center

The CB industry is worth billions, and is showing no signs of slowing down with many CB related companies now providing crowdfunding investment opp's to both accredited and non-accredited inve*stors who wish to participate in its growth. It may also help discover cures and treatments for cancer. Pharmagreen Biotech, with their S1 document now effective from the SEC, is one such company targeting cancer research and much more with their vision of multi-purpose CB Botany Centers.

Catalyst #3: Pharmagreen Signs a LOI for Supply of CB Dana Hemp Starter Plantlets

Pharmagreen Biotech, Inc. is pleased to announce that its Canadian subsidiary, WFS Pharmagreen Inc., has signed a Letter of Intent with Carpere Inc. for the supply of “CB Dana” hemp starter plantlets for the 2020 farming season and beyond.

The Pharmagreen team is excited to work with Carpere to be their supplier of all female high CB hemp starter plantlets to produce the highest quality high CB flower tops as well as production of the CB whole hemp oils and isolate. Carpere owns and manages farmland, on behalf of farmers, in excess of 100,000 acres throughout Canada.

-----

PHBI Company Services Are Cutting Edge

PLANT TISSUE CULTURE UNIT

CHIBAFREEN™ a new, highly evolved, state-of-the art in vitro plant production method is introduced by the company Botanical Research In Motion Inc. (B.R.I.M.) for exclusive use by WFS Pharmagreen Inc. for various kinds of high quality transplant production in the company’s Botany Center.

This proprietary process was developed by Dr. Fawzia Afreen.

In this method relatively small chlorophyllous (leafy) explants or single nodal cuttings are grown inside the culture vessel under pathogen free, sterile condition under artificial light.

The conventional in vitro system for transplant production involves four stages:

1) Initiation, 2) Multiplication, 3) Rooting and 4) Hardening.

In their new method one of the stages is eliminated, which reduce the production period and costs drastically. The root formation and the hardening of the plant are carried out using their new technology, coined as Chibafreen™ in vitro plant production. The CB Botany Center will produce approximately 10Mn plantlets at full capacity.

DNA TESTING SERVICES UNIT

Using DNA testing, growers can ensure they have the right genetics of plants to grow:

• protect their crops from uncertified plant species investment mitigate the risk of plant to yield ratios
• reduce losses from environmental conditions
• protect them from any financial damage

No other DNA commercial facility is in operation west of Manitoba. Saskatchewan Research Council (SRC’s ) Biotechnology Laboratories exists for scientific purposes only. B.R.I.M. will use SSR marker (Simple sequence repeat) technology to fingerprint varieties. We will develop an extensive database for several crops. Clients/growers simply need to collect leaf samples (300 – 500 g) of a suspect variety and our lab will compare its SSR fingerprint to varieties in our database. These services will be provided by B.R.I.M. as a value-added service for Pharmagreen’s Botany Center.

COLD STORAGE UNIT

Lowering temperature can slow the metabolic processes (e.g. respiration) and prevent undesirable loss of dry mass and associated deteriorations of quality. The proper combination of air temperature, light intensity and propriety techniques during storage would contribute to minimizing increase/decrease in dry weight and preserving photosynthetic ability and provide immediate regrowth of plantlets after storage.

First of its kind service for:

• To preserve clients plants strains and propagate them when necessary.
• To maintain a variety of plants species indefinitely with the immediate ability for mass reproduction.
• Flexible production schedule on a commercial scale is possible.

NURSERY UNIT

Year-round greenhouse structures will be built on the property to provide nursery service for CB plants inclusive of indica, sativa and hemp strains for the CB cultivators. The company will be working closely with industrial hemp farmers for the production of hemp strains with high CB content. B.R.I.M. Inc. has completed successful research on its high CB strain dubbed “CB DANA” which content is well over 10% in CB and the THC at below .03% which makes it ideal for industrial hemp farming.

“CB DANA” will be available for sale exclusively through Pharmagreen’s CB Botany Center.

EXTRACTION UNIT

Extraction service for CB plant oils will be provided for all clients as well as for future production of Pharmagreen brands of CB products for human use. Additionally, B.R.I.M. will be conducting research and development of CB formulations for Pharmagreen brands.

The extraction and distillation equipment will be certified medical grade equipment with a capacity for commercial scale production.

https://www.pharmagreen.ca

-----

-----

PHBI could be your next big breakout stock profile. Make sure it's on your radar before today's opening bell.

Sincerely,

Kai Parker

StockWireNews

Sources: finance.yahoo.com/news/smallcap-sentinel-hundred-times-better-110000095.html

(Always Remember The Stock Prices Could Be Significantly Lower Now From The Dates I Provided.)